Spiro-Lactams as Novel Antimicrobial Agents. 2020

Américo J S Alves, and Nuno G Alves, and Cátia C Caratão, and Margarida I M Esteves, and Diana Fontinha, and Inês Bártolo, and Maria I L Soares, and Susana M M Lopes, and Miguel Prudêncio, and Nuno Taveira, and Teresa M V D Pinho E Melo
CQC and Department of Chemistry, University of Coimbra, 3004-535 Coimbra, Portugal.

BACKGROUND Structural modulation of previously identified lead spiro-β-lactams with antimicrobial activity was carried out. OBJECTIVE The main objective of this work was to synthesize and evaluate the biological activity of novel spiro-lactams based on previously identified lead compounds with antimicrobial activity. METHODS The target chiral spiro-γ-lactams were synthesized through 1,3-dipolar cycloaddition reaction of a diazo-γ-lactam with electron-deficient dipolarophiles. In vitro activity against HIV and Plasmodium of a wide range of spiro-β-lactams and spiro-γ-lactams was evaluated. Among these compounds, one derivative with good anti-HIV activity and two with promising antiplasmodial activity (IC50 < 3.5 µM) were identified. RESULTS A novel synthetic route to chiral spiro-γ-lactams has been established. The studied β- and γ- lactams were not cytotoxic, and three compounds with promising antimicrobial activity were identified, whose structural modulation may lead to new and more potent drugs. CONCLUSIONS The designed structural modulation of biologically active spiro-β-lactams involved the replacement of the four-membered β-lactam ring by a five-membered γ-lactam ring. Although conformational and superimposition computational studies revealed no significant differences between β- and γ- lactam pharmacophoric features, the studied structural modulation did not lead to compounds with a similar biological profile. The observed results suggest that the β-lactamic core is a requirement for the activity against both HIV and Plasmodium.

UI MeSH Term Description Entries
D007769 Lactams Cyclic AMIDES formed from aminocarboxylic acids by the elimination of water. Lactims are the enol forms of lactams. Lactam,Lactim,Lactims
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D010961 Plasmodium A genus of protozoa that comprise the malaria parasites of mammals. Four species infect humans (although occasional infections with primate malarias may occur). These are PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE; PLASMODIUM OVALE, and PLASMODIUM VIVAX. Species causing infection in vertebrates other than man include: PLASMODIUM BERGHEI; PLASMODIUM CHABAUDI; P. vinckei, and PLASMODIUM YOELII in rodents; P. brasilianum, PLASMODIUM CYNOMOLGI; and PLASMODIUM KNOWLESI in monkeys; and PLASMODIUM GALLINACEUM in chickens. Plasmodiums
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D000981 Antiprotozoal Agents Substances that are destructive to protozoans. Schizonticides,Agents, Antiprotozoal
D013141 Spiro Compounds Cyclic compounds that include two rings which share a single atom (usually a carbon). The simplest example of this type of compound is Spiro[2.2]pentane, which looks like a bow tie. Compounds, Spiro
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV

Related Publications

Américo J S Alves, and Nuno G Alves, and Cátia C Caratão, and Margarida I M Esteves, and Diana Fontinha, and Inês Bártolo, and Maria I L Soares, and Susana M M Lopes, and Miguel Prudêncio, and Nuno Taveira, and Teresa M V D Pinho E Melo
September 2011, Bioorganic & medicinal chemistry letters,
Américo J S Alves, and Nuno G Alves, and Cátia C Caratão, and Margarida I M Esteves, and Diana Fontinha, and Inês Bártolo, and Maria I L Soares, and Susana M M Lopes, and Miguel Prudêncio, and Nuno Taveira, and Teresa M V D Pinho E Melo
August 2004, The Journal of organic chemistry,
Américo J S Alves, and Nuno G Alves, and Cátia C Caratão, and Margarida I M Esteves, and Diana Fontinha, and Inês Bártolo, and Maria I L Soares, and Susana M M Lopes, and Miguel Prudêncio, and Nuno Taveira, and Teresa M V D Pinho E Melo
September 1983, Die Pharmazie,
Américo J S Alves, and Nuno G Alves, and Cátia C Caratão, and Margarida I M Esteves, and Diana Fontinha, and Inês Bártolo, and Maria I L Soares, and Susana M M Lopes, and Miguel Prudêncio, and Nuno Taveira, and Teresa M V D Pinho E Melo
September 2019, European journal of medicinal chemistry,
Américo J S Alves, and Nuno G Alves, and Cátia C Caratão, and Margarida I M Esteves, and Diana Fontinha, and Inês Bártolo, and Maria I L Soares, and Susana M M Lopes, and Miguel Prudêncio, and Nuno Taveira, and Teresa M V D Pinho E Melo
June 2013, Bioorganic & medicinal chemistry,
Américo J S Alves, and Nuno G Alves, and Cátia C Caratão, and Margarida I M Esteves, and Diana Fontinha, and Inês Bártolo, and Maria I L Soares, and Susana M M Lopes, and Miguel Prudêncio, and Nuno Taveira, and Teresa M V D Pinho E Melo
April 2015, Tetrahedron letters,
Américo J S Alves, and Nuno G Alves, and Cátia C Caratão, and Margarida I M Esteves, and Diana Fontinha, and Inês Bártolo, and Maria I L Soares, and Susana M M Lopes, and Miguel Prudêncio, and Nuno Taveira, and Teresa M V D Pinho E Melo
September 1969, Tetrahedron,
Américo J S Alves, and Nuno G Alves, and Cátia C Caratão, and Margarida I M Esteves, and Diana Fontinha, and Inês Bártolo, and Maria I L Soares, and Susana M M Lopes, and Miguel Prudêncio, and Nuno Taveira, and Teresa M V D Pinho E Melo
January 2006, Molecules (Basel, Switzerland),
Américo J S Alves, and Nuno G Alves, and Cátia C Caratão, and Margarida I M Esteves, and Diana Fontinha, and Inês Bártolo, and Maria I L Soares, and Susana M M Lopes, and Miguel Prudêncio, and Nuno Taveira, and Teresa M V D Pinho E Melo
December 2020, Expert opinion on therapeutic patents,
Américo J S Alves, and Nuno G Alves, and Cátia C Caratão, and Margarida I M Esteves, and Diana Fontinha, and Inês Bártolo, and Maria I L Soares, and Susana M M Lopes, and Miguel Prudêncio, and Nuno Taveira, and Teresa M V D Pinho E Melo
May 2011, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!